Literature DB >> 28747374

Babesia microti: from Mice to Ticks to an Increasing Number of Highly Susceptible Humans.

Lars F Westblade1,2, Matthew S Simon2, Blaine A Mathison3, Laura A Kirkman4,5.   

Abstract

Babesia microti, a zoonotic intraerythrocytic parasite, is the primary etiological agent of human babesiosis in the United States. Human infections range from subclinical illness to severe disease resulting in death, with symptoms being related to host immune status. Despite advances in our understanding and management of B. microti, the incidence of infection in the United States has increased. Therefore, research focused on eradicating disease and optimizing clinical management is essential. Here we review this remarkable organism, with emphasis on the clinical, diagnostic, and therapeutic aspects of human disease.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Babesia microti; United States; clinical significance; diagnosis; epidemiology; immunosuppression; infection; life cycle; prevention; relapse; transmission; treatment

Mesh:

Substances:

Year:  2017        PMID: 28747374      PMCID: PMC5625376          DOI: 10.1128/JCM.00504-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  54 in total

1.  Vertically transmitted babesiosis.

Authors:  D L New; J B Quinn; M Z Qureshi; S J Sigler
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  Comparison of Babesia microti Real-Time Polymerase Chain Reaction Assays for Confirmatory Diagnosis of Babesiosis.

Authors:  Samaly S Souza; Henry S Bishop; Patrick Sprinkle; Yvonne Qvarnstrom
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

Review 3.  Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?

Authors:  Nabiha Huq Saifee; Peter J Krause; Yanyun Wu
Journal:  J Clin Apher       Date:  2015-10-20       Impact factor: 2.821

4.  Detection of Babesia microti parasites by highly sensitive 18S rRNA reverse transcription PCR.

Authors:  Amelia E Hanron; Zachary P Billman; Annette M Seilie; Ming Chang; Sean C Murphy
Journal:  Diagn Microbiol Infect Dis       Date:  2016-12-05       Impact factor: 2.803

5.  Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans.

Authors:  Guiqing Wang; Patrick Villafuerte; Jian Zhuge; Paul Visintainer; Gary P Wormser
Journal:  Diagn Microbiol Infect Dis       Date:  2015-03-18       Impact factor: 2.803

6.  Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.

Authors:  Gary P Wormser; Aakanksha Prasad; Ellen Neuhaus; Samit Joshi; John Nowakowski; John Nelson; Abraham Mittleman; Maria Aguero-Rosenfeld; Jeffrey Topal; Peter J Krause
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

Review 7.  Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review.

Authors:  Edgar Sanchez; Edouard Vannier; Gary P Wormser; Linden T Hu
Journal:  JAMA       Date:  2016-04-26       Impact factor: 56.272

Review 8.  Babesiosis diagnosis and treatment.

Authors:  Peter J Krause
Journal:  Vector Borne Zoonotic Dis       Date:  2003       Impact factor: 2.133

9.  Whole genome mapping and re-organization of the nuclear and mitochondrial genomes of Babesia microti isolates.

Authors:  Emmanuel Cornillot; Amina Dassouli; Aprajita Garg; Niseema Pachikara; Sylvie Randazzo; Delphine Depoix; Bernard Carcy; Stéphane Delbecq; Roger Frutos; Joana C Silva; Richard Sutton; Peter J Krause; Choukri Ben Mamoun
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

10.  Severe Babesia microti Infection in an Immunocompetent Host in Pennsylvania.

Authors:  Jeffrey Genda; Elizabeth A Negron; Mona Lotfipour; Samyuktha Balabhadra; Diana S Desai; David W Craft; Michael Katzman
Journal:  J Investig Med High Impact Case Rep       Date:  2016-08-22
View more
  16 in total

1.  Infection rates, species diversity, and distribution of zoonotic Babesia parasites in ticks: a global systematic review and meta-analysis.

Authors:  Solomon Ngutor Karshima; Magdalene Nguvan Karshima; Musa Isiyaku Ahmed
Journal:  Parasitol Res       Date:  2021-11-09       Impact factor: 2.289

2.  Specific and Sensitive Diagnosis of Babesia microti Active Infection Using Monoclonal Antibodies to the Immunodominant Antigen BmGPI12.

Authors:  Jacqueline Gagnon; Sushma Timalsina; Jae-Yeon Choi; Meenal Chand; Pallavi Singh; Pooja Lamba; Gauri Gaur; Anasuya C Pal; Sara Mootien; Luis A Marcos; Choukri Ben Mamoun; Michel Ledizet
Journal:  J Clin Microbiol       Date:  2022-08-30       Impact factor: 11.677

Review 3.  Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections.

Authors:  Christopher Schwake; Michael Hyon; Athar H Chishti
Journal:  Expert Opin Ther Targets       Date:  2022-03-07       Impact factor: 6.797

4.  Global meta-analysis on Babesia infections in human population: prevalence, distribution and species diversity.

Authors:  Solomon Ngutor Karshima; Magdalene Nguvan Karshima; Musa Isiyaku Ahmed
Journal:  Pathog Glob Health       Date:  2021-11-17       Impact factor: 3.735

Review 5.  The Blacklegged Tick, Ixodes scapularis: An Increasing Public Health Concern.

Authors:  Rebecca J Eisen; Lars Eisen
Journal:  Trends Parasitol       Date:  2018-01-11

6.  Evidence for vesicle-mediated antigen export by the human pathogen Babesia microti.

Authors:  Jose Thekkiniath; Nicole Kilian; Lauren Lawres; Meital A Gewirtz; Morven M Graham; Xinran Liu; Michel Ledizet; Choukri Ben Mamoun
Journal:  Life Sci Alliance       Date:  2019-06-13

Review 7.  Innate Lymphoid Cells in Protection, Pathology, and Adaptive Immunity During Apicomplexan Infection.

Authors:  Daria L Ivanova; Stephen L Denton; Kevin D Fettel; Kerry S Sondgeroth; Juan Munoz Gutierrez; Berit Bangoura; Ildiko R Dunay; Jason P Gigley
Journal:  Front Immunol       Date:  2019-02-28       Impact factor: 7.561

8.  Prevalence of Babesia spp. and clinical characteristics of Babesia vulpes infections in North American dogs.

Authors:  Nanelle R Barash; Brittany Thomas; Adam J Birkenheuer; Edward B Breitschwerdt; Erica Lemler; Barbara A Qurollo
Journal:  J Vet Intern Med       Date:  2019-07-23       Impact factor: 3.333

9.  Effective Therapy Targeting Cytochrome bc1 Prevents Babesia Erythrocytic Development and Protects from Lethal Infection.

Authors:  Joy E Chiu; Isaline Renard; Anasuya C Pal; Pallavi Singh; Pratap Vydyam; Jose Thekkiniath; Madelyn Kumar; Shalev Gihaz; Sovitj Pou; Rolf W Winter; Rozalia Dodean; Lisa Frueh; Aaron C Nilsen; Michael K Riscoe; J Stone Doggett; Choukri Ben Mamoun
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

10.  A library of recombinant Babesia microti cell surface and secreted proteins for diagnostics discovery and reverse vaccinology.

Authors:  Catherine M Elton; Marilis Rodriguez; Choukri Ben Mamoun; Cheryl A Lobo; Gavin J Wright
Journal:  Int J Parasitol       Date:  2018-10-24       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.